Pre-Order CLSI M100 Ed35 and Unlock Your Lab’s AST Potential
This annual update is an essential resource for microbiology laboratorians and clinicians, helping ensure accurate testing and treatment decisions.
WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.
CLSI brings together the worldwide laboratory community to advance a common cause.
This annual update is an essential resource for microbiology laboratorians and clinicians, helping ensure accurate testing and treatment decisions.
CLSI M100 Update Webinar 2025: Implement CLSI M100 With Confidence
Date: Wednesday, 26 February 2025 at 1:00-2:30 ET
Receive the latest guidance for implementing new breakpoints and standards into your laboratory practices, including discussion of the major changes in this edition, including:
CLSI M100-Ed35 includes updated tables for the Clinical and Laboratory Standards Institute antimicrobial susceptibility testing standards CLSI M02| Performance Standards for Antimicrobial Disk Susceptibility Tests, 14th Edition (2024), CLSI M07| Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 12th Edition (2024), and CLSI M11 | Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 9th Edition (2018).
CLSI GP40 provides guidelines on water purified for medical laboratory use, methods for monitoring water quality and testing for specific contaminants, and water system design considerations.
CLSI M64 includes recommendations for implementing nomenclature changes for medically important bacteria and fungi that are identified and reported from clinical specimens, especially when testing for antimicrobial susceptibility.
CLSI C34 describes methods for all aspects of sweat testing, including collection and analysis, results evaluation and reporting, and quality control.
CLSI QMS14 presents concepts and information to assist a laboratory in meeting leadership requirements for its quality management system. Guidance is provided for leaders to effectively design, implement, and maintain the cultural, structural, and functional aspects of their laboratory that are critical to managing and sustaining quality.
CLSI AUTO11 provides a framework for communication of information technology security issues between the in vitro diagnostic system vendor and the health care organization.
This practical guide, compiled with the help of experts from the in vitro diagnostics industry, is intended for the laboratory that is creating laboratory developed tests that may be subject to the US Food and Drug Administration (FDA) regulations, specifically the Quality System Regulation (QSReg), 21 CFR Part
CLSI and our volunteer members actively identify and develop new guidance on standards that raise laboratory testing quality, safety, and efficiency. We are setting the bar for how that guidance is delivered.
Learn more